| Evidence for gastrointestinal infection of SARS-CoV-2 F Xiao, M Tang, X Zheng, Y Liu, X Li, H Shan Gastroenterology 158 (6), 1831-1833. e3, 2020 | 3511 | 2020 |
| EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy J Lupberger, MB Zeisel, F Xiao, C Thumann, I Fofana, L Zona, C Davis, ... Nature medicine 17 (5), 589-595, 2011 | 849 | 2011 |
| Infectious SARS-CoV-2 in feces of patient with severe COVID-19 F Xiao, J Sun, Y Xu, F Li, X Huang, H Li, J Zhao, J Huang, J Zhao Emerging infectious diseases 26 (8), 1920, 2020 | 634 | 2020 |
| The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι Y Zhang, Y Chen, Y Li, F Huang, B Luo, Y Yuan, B Xia, X Ma, T Yang, ... Proceedings of the National Academy of Sciences 118 (23), e2024202118, 2021 | 411 | 2021 |
| Psychological status and behavior changes of the public during the COVID-19 epidemic in China X Liu, WT Luo, Y Li, CN Li, ZS Hong, HL Chen, F Xiao, JY Xia Infectious diseases of poverty 9 (03), 20-30, 2020 | 301 | 2020 |
| Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects E Bekerman, G Neveu, A Shulla, J Brannan, SY Pu, S Wang, F Xiao, ... The Journal of clinical investigation 127 (4), 1338-1352, 2017 | 232 | 2017 |
| HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex L Zona, J Lupberger, N Sidahmed-Adrar, C Thumann, HJ Harris, ... Cell host & microbe 13 (3), 302-313, 2013 | 196 | 2013 |
| Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes I Fofana, SE Krieger, F Grunert, S Glauben, F Xiao, S Fafi–Kremer, ... Gastroenterology 139 (3), 953-964. e4, 2010 | 196 | 2010 |
| Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody L Mailly, F Xiao, J Lupberger, GK Wilson, P Aubert, FHT Duong, ... Nature biotechnology 33 (5), 549-554, 2015 | 147 | 2015 |
| Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents F Xiao, I Fofana, L Heydmann, H Barth, E Soulier, F Habersetzer, ... PLoS pathogens 10 (5), e1004128, 2014 | 137 | 2014 |
| Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19 M Huang, M Li, F Xiao, P Pang, J Liang, T Tang, S Liu, B Chen, J Shu, ... National Science Review 7 (9), 1428-1436, 2020 | 136 | 2020 |
| Intra-host variation and evolutionary dynamics of SARS-CoV-2 populations in COVID-19 patients Y Wang, D Wang, L Zhang, W Sun, Z Zhang, W Chen, A Zhu, Y Huang, ... Genome Medicine 13, 1-13, 2021 | 118 | 2021 |
| Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C F Xiao, I Fofana, C Thumann, L Mailly, R Alles, E Robinet, N Meyer, ... Gut 64 (3), 483-494, 2015 | 109 | 2015 |
| Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment SY Pu, F Xiao, S Schor, E Bekerman, F Zanini, R Barouch-Bentov, ... Antiviral research 155, 67-75, 2018 | 99 | 2018 |
| The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination MN Zahid, M Turek, F Xiao, VL Dao Thi, M Guérin, I Fofana, P Bachellier, ... Hepatology 57 (2), 492-504, 2013 | 94 | 2013 |
| Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes Z Zhou, C Huang, Z Zhou, Z Huang, L Su, S Kang, X Chen, Q Chen, S He, ... IScience 24 (3), 2021 | 91 | 2021 |
| A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation S Kang, M Yang, S He, Y Wang, X Chen, YQ Chen, Z Hong, J Liu, G Jiang, ... Nature communications 12 (1), 2697, 2021 | 82 | 2021 |
| Epidermal growth factor receptor signaling impairs the antiviral activity of interferon‐alpha J Lupberger, FHT Duong, I Fofana, L Zona, F Xiao, C Thumann, ... Hepatology 58 (4), 1225-1235, 2013 | 70 | 2013 |
| A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission I Fofana, F Xiao, C Thumann, M Turek, L Zona, RG Tawar, F Grunert, ... PloS one 8 (5), e64221, 2013 | 67 | 2013 |
| Hepatitis C virus proteins interact with the endosomal sorting complex required for transport (ESCRT) machinery via ubiquitination to facilitate viral envelopment R Barouch-Bentov, G Neveu, F Xiao, M Beer, E Bekerman, S Schor, ... MBio 7 (6), 10.1128/mbio. 01456-16, 2016 | 59 | 2016 |
